nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A2—Cytarabine—lymphatic system cancer	0.253	0.324	CbGbCtD
Epinephrine—SLC22A1—Cytarabine—lymphatic system cancer	0.22	0.281	CbGbCtD
Epinephrine—CYP1A2—Carmustine—lymphatic system cancer	0.113	0.145	CbGbCtD
Epinephrine—CYP2C9—Teniposide—lymphatic system cancer	0.0683	0.0875	CbGbCtD
Epinephrine—CYP3A4—Cytarabine—lymphatic system cancer	0.0403	0.0517	CbGbCtD
Epinephrine—CYP3A4—Teniposide—lymphatic system cancer	0.0397	0.0509	CbGbCtD
Epinephrine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0278	0.0356	CbGbCtD
Epinephrine—CYP3A4—Vincristine—lymphatic system cancer	0.0191	0.0245	CbGbCtD
Epinephrine—Skin necrosis—Carmustine—lymphatic system cancer	0.00605	0.0276	CcSEcCtD
Epinephrine—Hemiplegia—Carmustine—lymphatic system cancer	0.00592	0.027	CcSEcCtD
Epinephrine—Rales—Bleomycin—lymphatic system cancer	0.0059	0.0269	CcSEcCtD
Epinephrine—Ischaemia—Mitoxantrone—lymphatic system cancer	0.00539	0.0246	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Fludarabine—lymphatic system cancer	0.00504	0.023	CcSEcCtD
Epinephrine—Pallor—Teniposide—lymphatic system cancer	0.00453	0.0207	CcSEcCtD
Epinephrine—Local reaction—Bleomycin—lymphatic system cancer	0.00437	0.0199	CcSEcCtD
Epinephrine—Extravasation—Teniposide—lymphatic system cancer	0.00431	0.0196	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Carmustine—lymphatic system cancer	0.00382	0.0174	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Vincristine—lymphatic system cancer	0.00364	0.0166	CcSEcCtD
Epinephrine—Local reaction—Mitoxantrone—lymphatic system cancer	0.00355	0.0162	CcSEcCtD
Epinephrine—Skin necrosis—Methotrexate—lymphatic system cancer	0.0028	0.0128	CcSEcCtD
Epinephrine—Extravasation—Bleomycin—lymphatic system cancer	0.00278	0.0127	CcSEcCtD
Epinephrine—Necrosis—Carmustine—lymphatic system cancer	0.00269	0.0123	CcSEcCtD
Epinephrine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00257	0.0117	CcSEcCtD
Epinephrine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00256	0.0117	CcSEcCtD
Epinephrine—Necrosis—Mitoxantrone—lymphatic system cancer	0.0025	0.0114	CcSEcCtD
Epinephrine—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00245	0.0112	CcSEcCtD
Epinephrine—Myocardial ischaemia—Mitoxantrone—lymphatic system cancer	0.00244	0.0111	CcSEcCtD
Epinephrine—Extravasation—Carmustine—lymphatic system cancer	0.00242	0.011	CcSEcCtD
Epinephrine—Rales—Methotrexate—lymphatic system cancer	0.00239	0.0109	CcSEcCtD
Epinephrine—Extravasation—Vincristine—lymphatic system cancer	0.00231	0.0105	CcSEcCtD
Epinephrine—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00231	0.0105	CcSEcCtD
Epinephrine—Drug interaction—Carmustine—lymphatic system cancer	0.00228	0.0104	CcSEcCtD
Epinephrine—Extravasation—Mitoxantrone—lymphatic system cancer	0.00225	0.0103	CcSEcCtD
Epinephrine—Contusion—Mitoxantrone—lymphatic system cancer	0.00225	0.0103	CcSEcCtD
Epinephrine—Drug interaction—Vincristine—lymphatic system cancer	0.00218	0.00992	CcSEcCtD
Epinephrine—Nephropathy—Methotrexate—lymphatic system cancer	0.00206	0.00938	CcSEcCtD
Epinephrine—Sweating increased—Fludarabine—lymphatic system cancer	0.00202	0.0092	CcSEcCtD
Epinephrine—Skin exfoliation—Carmustine—lymphatic system cancer	0.00202	0.0092	CcSEcCtD
Epinephrine—Sweating—Teniposide—lymphatic system cancer	0.00202	0.00919	CcSEcCtD
Epinephrine—Disorientation—Bleomycin—lymphatic system cancer	0.00197	0.00896	CcSEcCtD
Epinephrine—Haemoglobin—Teniposide—lymphatic system cancer	0.0019	0.00865	CcSEcCtD
Epinephrine—Haemorrhage—Teniposide—lymphatic system cancer	0.00189	0.0086	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00188	0.00859	CcSEcCtD
Epinephrine—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00187	0.00852	CcSEcCtD
Epinephrine—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00182	0.0083	CcSEcCtD
Epinephrine—Renal failure—Fludarabine—lymphatic system cancer	0.00182	0.00828	CcSEcCtD
Epinephrine—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00181	0.00826	CcSEcCtD
Epinephrine—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00179	0.00818	CcSEcCtD
Epinephrine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00177	0.00805	CcSEcCtD
Epinephrine—Flushing—Teniposide—lymphatic system cancer	0.00175	0.00799	CcSEcCtD
Epinephrine—Arrhythmia—Teniposide—lymphatic system cancer	0.00169	0.00769	CcSEcCtD
Epinephrine—Haemoglobin—Fludarabine—lymphatic system cancer	0.00167	0.0076	CcSEcCtD
Epinephrine—Haemorrhage—Fludarabine—lymphatic system cancer	0.00166	0.00756	CcSEcCtD
Epinephrine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00165	0.00752	CcSEcCtD
Epinephrine—Agitation—Teniposide—lymphatic system cancer	0.00151	0.00688	CcSEcCtD
Epinephrine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00148	0.00676	CcSEcCtD
Epinephrine—Hypertension—Teniposide—lymphatic system cancer	0.00142	0.00647	CcSEcCtD
Epinephrine—Chest pain—Teniposide—lymphatic system cancer	0.0014	0.00638	CcSEcCtD
Epinephrine—Hypokalaemia—Carmustine—lymphatic system cancer	0.0014	0.00637	CcSEcCtD
Epinephrine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00134	0.00609	CcSEcCtD
Epinephrine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00133	0.00605	CcSEcCtD
Epinephrine—Agitation—Fludarabine—lymphatic system cancer	0.00133	0.00605	CcSEcCtD
Epinephrine—Tachycardia—Teniposide—lymphatic system cancer	0.00131	0.00597	CcSEcCtD
Epinephrine—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.0013	0.00592	CcSEcCtD
Epinephrine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0013	0.00591	CcSEcCtD
Epinephrine—Necrosis—Methotrexate—lymphatic system cancer	0.00125	0.00569	CcSEcCtD
Epinephrine—Haemoglobin—Bleomycin—lymphatic system cancer	0.00122	0.00557	CcSEcCtD
Epinephrine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00122	0.00554	CcSEcCtD
Epinephrine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00121	0.00552	CcSEcCtD
Epinephrine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.0012	0.00548	CcSEcCtD
Epinephrine—Hyperglycaemia—Carmustine—lymphatic system cancer	0.0012	0.00545	CcSEcCtD
Epinephrine—Renal failure—Carmustine—lymphatic system cancer	0.00116	0.0053	CcSEcCtD
Epinephrine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00116	0.00527	CcSEcCtD
Epinephrine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00116	0.00527	CcSEcCtD
Epinephrine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00114	0.00519	CcSEcCtD
Epinephrine—Flushing—Bleomycin—lymphatic system cancer	0.00113	0.00515	CcSEcCtD
Epinephrine—Extravasation—Methotrexate—lymphatic system cancer	0.00112	0.00512	CcSEcCtD
Epinephrine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00111	0.00507	CcSEcCtD
Epinephrine—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00111	0.00507	CcSEcCtD
Epinephrine—Myocardial infarction—Vincristine—lymphatic system cancer	0.00111	0.00504	CcSEcCtD
Epinephrine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0011	0.00501	CcSEcCtD
Epinephrine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00108	0.00494	CcSEcCtD
Epinephrine—Sweating—Vincristine—lymphatic system cancer	0.00108	0.00493	CcSEcCtD
Epinephrine—Renal failure—Mitoxantrone—lymphatic system cancer	0.00108	0.00493	CcSEcCtD
Epinephrine—Nausea—Mechlorethamine—lymphatic system cancer	0.00108	0.00493	CcSEcCtD
Epinephrine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00108	0.00491	CcSEcCtD
Epinephrine—Haemoglobin—Carmustine—lymphatic system cancer	0.00107	0.00486	CcSEcCtD
Epinephrine—Haemorrhage—Carmustine—lymphatic system cancer	0.00106	0.00484	CcSEcCtD
Epinephrine—Erythema—Bleomycin—lymphatic system cancer	0.00106	0.00483	CcSEcCtD
Epinephrine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00106	0.00482	CcSEcCtD
Epinephrine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00106	0.00482	CcSEcCtD
Epinephrine—Hallucination—Carmustine—lymphatic system cancer	0.00106	0.00482	CcSEcCtD
Epinephrine—Sweating—Mitoxantrone—lymphatic system cancer	0.00105	0.00481	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00102	0.00464	CcSEcCtD
Epinephrine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00101	0.0046	CcSEcCtD
Epinephrine—Hallucination—Vincristine—lymphatic system cancer	0.00101	0.0046	CcSEcCtD
Epinephrine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000992	0.00452	CcSEcCtD
Epinephrine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000987	0.0045	CcSEcCtD
Epinephrine—Flushing—Carmustine—lymphatic system cancer	0.000985	0.00449	CcSEcCtD
Epinephrine—Arrhythmia—Carmustine—lymphatic system cancer	0.000948	0.00432	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000935	0.00426	CcSEcCtD
Epinephrine—Mental disorder—Carmustine—lymphatic system cancer	0.00093	0.00424	CcSEcCtD
Epinephrine—Erythema—Carmustine—lymphatic system cancer	0.000924	0.00421	CcSEcCtD
Epinephrine—Chest pain—Bleomycin—lymphatic system cancer	0.000901	0.00411	CcSEcCtD
Epinephrine—Mental disorder—Vincristine—lymphatic system cancer	0.000888	0.00405	CcSEcCtD
Epinephrine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000882	0.00402	CcSEcCtD
Epinephrine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000872	0.00397	CcSEcCtD
Epinephrine—Erythema—Mitoxantrone—lymphatic system cancer	0.000859	0.00392	CcSEcCtD
Epinephrine—Vomiting—Teniposide—lymphatic system cancer	0.000853	0.00389	CcSEcCtD
Epinephrine—Agitation—Carmustine—lymphatic system cancer	0.000849	0.00387	CcSEcCtD
Epinephrine—Agitation—Vincristine—lymphatic system cancer	0.000811	0.0037	CcSEcCtD
Epinephrine—Hypertension—Carmustine—lymphatic system cancer	0.000798	0.00364	CcSEcCtD
Epinephrine—Nausea—Teniposide—lymphatic system cancer	0.000796	0.00363	CcSEcCtD
Epinephrine—Chest pain—Carmustine—lymphatic system cancer	0.000787	0.00359	CcSEcCtD
Epinephrine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000776	0.00354	CcSEcCtD
Epinephrine—Hypertension—Vincristine—lymphatic system cancer	0.000762	0.00347	CcSEcCtD
Epinephrine—Vomiting—Fludarabine—lymphatic system cancer	0.000749	0.00342	CcSEcCtD
Epinephrine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000742	0.00338	CcSEcCtD
Epinephrine—Tachycardia—Carmustine—lymphatic system cancer	0.000736	0.00336	CcSEcCtD
Epinephrine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000731	0.00333	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000725	0.00331	CcSEcCtD
Epinephrine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000706	0.00322	CcSEcCtD
Epinephrine—Nausea—Fludarabine—lymphatic system cancer	0.0007	0.00319	CcSEcCtD
Epinephrine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000696	0.00317	CcSEcCtD
Epinephrine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000684	0.00312	CcSEcCtD
Epinephrine—Insomnia—Carmustine—lymphatic system cancer	0.000682	0.00311	CcSEcCtD
Epinephrine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000681	0.00311	CcSEcCtD
Epinephrine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000678	0.00309	CcSEcCtD
Epinephrine—Paraesthesia—Carmustine—lymphatic system cancer	0.000677	0.00309	CcSEcCtD
Epinephrine—Somnolence—Carmustine—lymphatic system cancer	0.000671	0.00306	CcSEcCtD
Epinephrine—Insomnia—Vincristine—lymphatic system cancer	0.000651	0.00297	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000651	0.00297	CcSEcCtD
Epinephrine—Paraesthesia—Vincristine—lymphatic system cancer	0.000647	0.00295	CcSEcCtD
Epinephrine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00063	0.00287	CcSEcCtD
Epinephrine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000623	0.00284	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000622	0.00283	CcSEcCtD
Epinephrine—Vomiting—Bleomycin—lymphatic system cancer	0.000549	0.0025	CcSEcCtD
Epinephrine—Drowsiness—Methotrexate—lymphatic system cancer	0.000548	0.0025	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—lymphatic system cancer	0.000538	0.00245	CcSEcCtD
Epinephrine—Sweating—Methotrexate—lymphatic system cancer	0.000525	0.00239	CcSEcCtD
Epinephrine—Nausea—Bleomycin—lymphatic system cancer	0.000513	0.00234	CcSEcCtD
Epinephrine—Dizziness—Carmustine—lymphatic system cancer	0.000499	0.00227	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000494	0.00225	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000492	0.00224	CcSEcCtD
Epinephrine—Vomiting—Carmustine—lymphatic system cancer	0.00048	0.00219	CcSEcCtD
Epinephrine—Dizziness—Vincristine—lymphatic system cancer	0.000476	0.00217	CcSEcCtD
Epinephrine—Vomiting—Vincristine—lymphatic system cancer	0.000458	0.00209	CcSEcCtD
Epinephrine—Nausea—Carmustine—lymphatic system cancer	0.000448	0.00204	CcSEcCtD
Epinephrine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000446	0.00203	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—lymphatic system cancer	0.000431	0.00196	CcSEcCtD
Epinephrine—Erythema—Methotrexate—lymphatic system cancer	0.000428	0.00195	CcSEcCtD
Epinephrine—Nausea—Vincristine—lymphatic system cancer	0.000428	0.00195	CcSEcCtD
Epinephrine—Nausea—Mitoxantrone—lymphatic system cancer	0.000416	0.0019	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—lymphatic system cancer	0.000364	0.00166	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000362	0.00165	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000343	0.00156	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—lymphatic system cancer	0.000339	0.00155	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000338	0.00154	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—lymphatic system cancer	0.000316	0.00144	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000314	0.00143	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—lymphatic system cancer	0.000311	0.00142	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000302	0.00138	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—lymphatic system cancer	0.000231	0.00105	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—lymphatic system cancer	0.000222	0.00101	CcSEcCtD
Epinephrine—Nausea—Methotrexate—lymphatic system cancer	0.000208	0.000946	CcSEcCtD
